.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Cerilliant
Fuji
Cipla
Medtronic
Dow
AstraZeneca
Boehringer Ingelheim
US Army
Johnson and Johnson

Generated: November 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040782

« Back to Dashboard
NDA 040782 describes DIPYRIDAMOLE, which is a drug marketed by Glenmark Generics, Hospira, Barr, West-ward Pharms Int, Purepac Pharm, Murty Pharms, Athenex Inc, Oxford Pharms, Idt Australia Ltd, Teva Pharms Usa, Fresenius Kabi Usa, Watson Labs, Mylan Labs Ltd, Zydus Pharms Usa Inc, Impax Labs, and Lannett, and is included in twenty-two NDAs. It is available from eleven suppliers. Additional details are available on the DIPYRIDAMOLE profile page.

The generic ingredient in DIPYRIDAMOLE is dipyridamole. There are eighteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the dipyridamole profile page.

Summary for 040782

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Blood Products/Modifiers/ Volume Expanders
Formulation / Manufacturing:see details

Pharmacology for NDA: 040782

Physiological EffectDecreased Platelet Aggregation

Medical Subject Heading (MeSH) Categories for 040782

Suppliers and Packaging for NDA: 040782

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DIPYRIDAMOLE
dipyridamole
TABLET;ORAL 040782 ANDA Cardinal Health 55154-4325 55154-4325-8 10 BLISTER PACK in 1 BAG (55154-4325-8) > 1 TABLET, FILM COATED in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Jul 18, 2007TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Jul 18, 2007TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength75MG
Approval Date:Jul 18, 2007TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
UBS
Novartis
Colorcon
Citi
Mallinckrodt
Deloitte
Accenture
McKesson
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot